New Hope Research Development — Corona, California

New Hope Research Development is a clinical research site located in Corona, California, United States 92882.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

New Hope Research Development has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Gastroparesis, Type 2 Diabetes, Diabetes Mellitus, Type 2.

Sponsors: CinDome Pharma, Inc., Eli Lilly and Company, MicuRx.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Hope Research Development?

New Hope Research Development has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Hope Research Development conducted?

New Hope Research Development has 4 clinical trials on record, with 1 currently active. Their work covers Diabetic Gastroparesis, Type 2 Diabetes, Diabetes Mellitus, Type 2.

Is New Hope Research Development accredited by Crixeo Health?

New Hope Research Development has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Hope Research Development?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.